Stephanie Graff, MD, FACP, FASCO

@DrSGraff · Barrington, RI · joined 05 Mar 2017

Director Breast Oncology, Brown University Health | Assoc Prof Legorreta Cancer Center Brown Univ | Views Mine | https://t.co/WVUQaIHeKn | COI ⬇

21 825Followers

3 585Following

15 597Posts total

133.3KViews on collected posts

Latest posts

Stephanie Graff, MD, FACP, FASCO@DrSGraff8 Sep

The age of resistance monitoring has arrived. ctDNA + camizestrant enter the ER+ metastatic breast cancer pathway. 3K views · 23 likes · 8 reposts · 2 replies Open on X →

Stephanie Graff, MD, FACP, FASCO@DrSGraff4 Sep

The FDA 🇺🇸granted accelerated approval to camizestrant, combined with a CDK4/6 inhibitor, for HR-positive, 🧬HER2-negative advanced #BreastCancer patients who develop ESR1 mutations during aromatase inhibitor and CDK4/6 inhibitor therapy. https://t.co/ds2x79NbcO @hoperugo https:

10.2K views · 33 likes · 19 reposts · 2 replies Open on X →

Stephanie Graff, MD, FACP, FASCO@DrSGraff13 Aug

#BCSM advocacy friends—who should be my go-to advocate for ER-low disease? @JaniceTNBCmets @itsnot_pink @christeeny513 @stage4kelly @AMJohnston1315 @abcdiagnosis 1K views · 6 likes · 1 reposts · 2 replies Open on X →

Stephanie Graff, MD, FACP, FASCO@DrSGraff1 Aug

Biology continues to be more complicated than stage. 5.8K views · 30 likes · 8 reposts · 1 replies Open on X →

Stephanie Graff, MD, FACP, FASCO@DrSGraff31 Jul

🔵Real-world HR+/HER2− early #BreastCancer (Flatiron EHR, n=7,481; 78-mo FU). N0 with high-risk features had recurrence & mortality risk comparable to N1, indicating meaningful risk beyond nodal status. 🖋️@PTarantinoMD @DrSGraff 🔗 https://t.co/xlqmVhLG5P 21.2K views · 37 likes · 9 reposts · 1 replies Open on X →

Stephanie Graff, MD, FACP, FASCO@DrSGraff23 Jul

Beautiful essay by Don Dizon. “I came to understand that honesty and hope were not opposites, though holding them together was an art.” The last lines are my favorite—but I won’t spoil it! You Are an Island, Son, Like It or Not | NEJM Voices https://t.co/3cZDaGEqpu 1.8K views · 24 likes · 6 reposts · 5 replies Open on X →

Stephanie Graff, MD, FACP, FASCO@DrSGraff29 Mar 2024

@DrSGraff @ASCO Wonderful to watch @DrSGraff — A full day in a very full and loving life! ❤️ 105 views · 2 likes · 0 reposts · 0 replies Open on X →

Stephanie Graff, MD, FACP, FASCO@DrSGraff17 Mar 2024

@DrSGraff @ASCO It’s 30 hrs in 24hr day, so inspiring how you balance everything!! 51 views · 1 likes · 0 reposts · 0 replies Open on X →

Stephanie Graff, MD, FACP, FASCO@DrSGraff10 Nov 2023

@DrSGraff @ASCO Superb 👏 67 views · 1 likes · 0 reposts · 0 replies Open on X →

Stephanie Graff, MD, FACP, FASCO@DrSGraff9 Nov 2023

Thanks @ASCO for asking me to share a #DayInTheLife as breast oncologist, researcher, leader, educator, mom. Here we capture a large piece. Other days are packed w/patient care (✨the best), and then there’a a mix of like this. I ❤️ my #oncology life. It’s the best job! 39.2K views · 138 likes · 18 reposts · 12 replies Open on X →

Stephanie Graff, MD, FACP, FASCO@DrSGraff9 Nov 2023

Follow along with breast oncologist & ASCO member @DrSGraff as she takes you through a #DayInTheLife, juggling cancer research, lectures & collaborations, family time, and more! On other days, her time is spent in clinic caring for patients with breast cancer. https://t.co/VYGjUT

0:58

51K views · 23 likes · 5 reposts · 1 replies Open on X →

Against accounts of the same size

6 posts from the last 90 days, next to the 10K–100K follower range. shown widely, but few of those viewers react.

Median views4 372this account924median for 10K–100K

Reach, %20.03%this account3.62%median for 10K–100K

Engagement, %0.78%this account1.52%median for 10K–100K

Metric	This account	Median for 10K–100K	Ratio
Median views per post	4 372	924	4.73×
Reach (views ÷ followers)	20.03%	3.62%	5.53×
Engagement rate	0.78%	1.52%	0.51×

Others in this range → Compare with another account → How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

51K9 Nov

39.2K

6710 Nov

5117 Mar

10529 Mar

1.8K23 Jul

21.2K31 Jul

5.8K1 Aug

1K13 Aug

10.2K4 Sep

3K8 Sep

Last 11 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.06%9 Nov

0.43%

1.49%10 Nov

1.96%17 Mar

1.90%29 Mar

1.99%23 Jul

0.24%31 Jul

0.68%1 Aug

0.88%13 Aug

0.56%4 Sep

1.10%8 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes69.3%318 in total

Reposts16.1%74 in total

Replies5.7%26 in total

Quotes1.5%7 in total

Bookmarks7.4%34 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.